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Abstract
Background: Occult Hepatitis B Infection (OBI) is characterized by absence of serum HBsAg and persistence of
HBV-DNA in liver tissue, with low to undetectable serum HBV-DNA. The mechanisms underlying OBI remain to be
clarified. To evaluate if specific point mutations of HBV genome may be associated with OBI, we applied an
approach based on bioinformatics analysis of complete genome HBV sequences. In addition, the feasibility of
bioinformatics prediction models to classify HBV infections into OBI and non-OBI by molecular data was evaluated.
Methods: 41 OBI and 162 non-OBI complete genome sequences were retrieved from GenBank, aligned and
subjected to univariable analysis including statistical evaluation. Their S coding region was analyzed for Stop codon
mutations too, while S amino acid variability could be evaluated for genotype D only, due to the too small
number of available complete genome OBI sequences from other genotypes.
Prediction models were derived by multivariable analysis using Logistic Regression, Rule Induction and Random
Forest approaches, with extra-sample error estimation by Multiple ten-fold Cross-Validation (MCV). Models were
compared by t-test on the Area Under the Receiver Operating Characteristic curve (AUC) distributions obtained
from the MCV runs for each model against the best-performing model.
Results: Variations in seven nucleotide positions were significantly associated with OBI, and occurred in 11 out of
41 OBI sequences (26.8%): likely, other mutations did not reach statistical significance due to the small size of OBI
dataset. All variations affected at least one HBV coding region, but none of them mapped to regulative elements.
All viral proteins, with the only exception of the X, were affected. Stop codons in the S, that might account for
absence of serum HBsAg, were not significantly enriched in OBI sequences. In genotype D, amino acid variability in
the S was higher in OBI than non-OBI, particularly in the immunodominant region. A Random Forest prediction
model showed the best performance, but all models were not satisfactory in terms of specificity, due to the small
sample size of OBIs; however results are promising in the perspective of a broader dataset of complete genome
OBI sequences.
Conclusions: Data suggest that point mutations rarely occur in regulative elements of HBV, if ever, and contribute
to OBI by affecting different viral proteins, suggesting heterogeneous mechanisms may be responsible for OBI,
including, at least in genotype D, an escape mutation mechanism due to imperfect immune control. It appears
possible to derive prediction models based on molecular data when a larger set of complete genome OBI
sequences will become available.
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Hepatitis B virus (HBV) acute infection, often asympto-
matic, can be followed by recovery or by virus persis-
tence. At least three distinct clinical states of viral
persistence have been defined based on serological find-
ings: chronic hepatitis B, silent or “healthy” carrier, and
“occult hepatitis B” [1].
In a typical persistent HBV infection, individuals are
positive for both HBV DNA and HBsAg. In occult hepa-
titis B infection (OBI) individuals show very low level
s e r u mH B VD N A( <2 0 0I U / m l )b u ta r en e g a t i v ef o r
serum HBsAg by currently available assays [2]. Actually,
these patients represent the serologically detectable OBI
fraction, because patients have been also described with
detectable HBV DNA in the liver but undetectable HBV
DNA in the serum. Accordingly, an international meet-
ing stated OBI as “presence of HBV DNA in the liver
(with detectable or undetectable HBV DNA in the
serum) of individuals testing HBsAg negative by cur-
rently available assays” [2,3]. About one half OBI
patients is positive for anti-HBc and/or anti-HBs (sero-
positive-OBI), while the other half is negative for both
antibodies (seronegative-OBI) [2].
The mechanisms underlying OBI have been the object
of several studies but remain to be clarified. Most pub-
lished studies searching for HBV mutations possibly
related to this particular clinical status focused on analy-
sis of a fragment of HBV genome (mostly the region
coding for HBsAg), while those studies analyzing com-
plete HBV genomes focused on analysis of a specific
HBV genotype from a small group of patients or from a
specific geographic area [4-6]. No features common to
all OBI genotypes have been identified.
At least in a fraction of OBI, absence of HBsAg might
be due to mutations in HBsAg coding region, affecting
export or leading to HBsAg with reduced immuno-reac-
tivity with available monoclonal assays [7]. However,
assay sensitivity cannot explain a major biological fea-
ture of OBI, i.e. the low level of serum HBV-DNA. The
genome of HBV includes several regulative elements,
such as promoters, Enhancer I and II which provide
strong position- and orientation-independent increase of
transcription from the major HBV promoters, the Post-
transcriptional Regulative Element (PRE) promoting the
export of viral transcripts otherwise inefficient due to
absence of splicing, Direct Repeat 1 and 2 (DR1 and
DR2) involved in genome replication, binding sites for
transcription factors and others. Overall, these elements
regulate, directly or indirectly, HBV replication, tran-
scription and translation and, thus, any mutation affect-
ing them might theoretically modify the precise
modulation of HBV gene expression, essential for effi-
cient replication of the virus. Whether or not mutations
in regulative elements of HBV genome may be involved
in OBI has not been clearly established.
In the present study, we attempted to search for point
mutations possibly associated to OBI clinical status by
analyzing complete genome HBV sequences belonging
to several genotypes. A dataset of 41 complete genome
HBV sequences from OBI patients ("OBI dataset”), and
a dataset of 162 HBV sequences from non-OBI patients
("non-OBI dataset”) were retrieved from GenBank. They
were analysed by a computational approach including
statistical evaluation. The feasibility of bioinformatics
prediction models to classify HBV sequences into OBI
and non-OBI by molecular data was also evaluated. In
addition, we analyzed the predicted amino acid
sequences of the S open reading frame (ORF) of OBI
and non-OBI sequences for the presence of Stop
codons, that might account for absence of serum
HBsAg in OBI. Finally, high amino acid mutation rate
in the Small S protein has been recently reported in
genotype D OBIs [7]: we could evaluate S amino acid
variability in genotype D only OBIs, due to the too
small number of available complete genome sequences
from other genotypes.
Methods
Datasets of HBV sequences
Two datasets of complete genome HBV sequences were
built by downloading HBV sequences from GenBank: an
“OBI dataset”, i.e. a dataset of HBV sequences from OBI
patients, and a “non-OBI dataset”,i . e .ad a t a s e to fH B V
sequences from patients with typical HBV infection.
OBI sequences were identified by database searching
for “occult” and “hepatitis B” keywords. Each sequence
was verified to be effectively classified by its authors as a
true OBI sequence by examining annotations and/or by
searching informations in the published study in which
each sequence was reported. When more than one
cloned sequence from the same patient was available,
only one of them was randomly selected and included
in the dataset. HBV sequences from patients reported to
be infected by multiple (more than one) genotypes were
not included. Overall, 41 OBI sequences from 41
patients could be retrieved, representing the A, C, D
and E genotypes (Table 1).
The non-OBI control dataset was built by including
sequences according to the following criteria: (a)
matched non-OBI sequences described in the same stu-
dies reporting OBI sequences, (b) similar genotype
representation as in the dataset of OBI sequences and
(c) as much as possible, similar geographical origin as in
the dataset of OBI sequences.
Overall, 162 non-OBI sequences were retrieved, repre-
senting the same A, C, D and E genotypes as in the OBI
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roughly 1:4.
The complete list of Accession number of all
sequences is reported in Additional File 1, Table S1.
Univariable and multivariable sequence analysis
HBV sequences were aligned using Opal software [8].
Columns containing gaps and ambiguous base codes
were treated as missing information, in order to be as
much restrictive as possible with respect to putative
sequencing errors.
T h ef i n a la l i g n m e n tw a se n c o d e di n t oas e to fc a t e g o -
rical variables for each base position and into another
set of categorical variables for triplets of bases spanning
the whole set of frame translations. The outcome vari-
able was binary, coding OBI vs. non-OBI phenotype.
Univariable analysis was performed using Fisher’s
exact test on each categorical variable and the outcome,
adjusting obtained p-values with Benjamini-Hochberg
procedure [9].
Multivariable analysis was carried out either on the
encoded input set of bases or triplets (whole set or
reduced set by filtering positions found to be significant
under univariable analysis) using either Logistic Regres-
sion (LR) with LogitBoost and AIC feature selection
[10], or rule induction (RI) [11], or Random Forest (RF)
feature evaluation with Gini index [12]. In order to
account for the possible bias induced in RF by different
and elevated number of categories, we performed an
adjusted t-test statistic on the Gini distributions by com-
paring the values from 30 independent RF runs and 30
independent RF runs with outcome shuffling, similar to
a previously presented procedure [13].
Extra-sample error estimation for LR, RI, and RF was
a s s e s s e db yM u l t i p l et e n - f o l d Cross-Validation (MCV),
executed 10 times. Goodness-of-fit indicators were the
Area Under the Receiver Operating Characteristic curve
(AUC) [14], accuracy, specificity and sensitivity. Model
comparison was made by executing t-test with Bengio’s
correction for sample overlap [15] on the AUC
d i s t r i b u t i o n so b t a i n e df r o mt h eM C Vr u n sf o re a c h
model against the best-performing model.
Analyses were performed using R [16] and Weka open
source software [17].
Analysis of the Small S coding region of OBI and non-OBI
sequences
The Small S of OBI and non-OBI nucleotide sequences
w a st r a n s l a t e db yt h eB i o E d i tS e q u e n c eA l i g n m e n tE d i -
tor [18] and the obtained amino acid sequences were
analyzed for the presence of Stop codons.
To compare variability of genotype D OBI and non-
OBI sequences, entropy values (Hx) along the 226
amino acids of the Small S protein were calculated and
plotted using the Entropy plot tool of BioEdit. The
entropy value is a measure for nucleotide or amino acid
variation at a given position in aligned sequences; it var-
ies from 0 (i.e. no variation) to 3.04 (i.e. all the possible
20 amino acids or a gap occur in equal frequency).
The Major Hydrophilic Region (MHR) of 19 genotype
D OBI amino acid sequences was analyzed for substitu-
tions by comparison with a consensus MHR from 70
genotype D non-OBI sequences, that resulted to be
identical to the consensus obtained by Chaar et al. from
20 genotype D non-OBI sequences [7].
Results
Univariable analysis
Sequences from the OBI and non-OBI datasets were
compared by univariable analysis. Table 2 summarizes
HBV nucleotide positions (categorical variables) signifi-
cantly enriched in the OBI dataset vs. non-OBI dataset,
as well as the corresponding amino acid changes.
Significant nucleotides are distributed in three ORFs: poly-
merase (in the RT and TP domains) [19], surface (in the
Pre-S2 and S domains) and core (T-helper epitope region
and Arg-rich C-terminus) [20,21]; none affects the X ORF.
Due to the organization of HBV genome with overlap-
ping coding regions, four positions (nucleotide 78, 233,
418 and 2435) affect simultaneously two ORFs. However,
Table 1 Summary of sequences included in OBI and non-OBI datasets, by country and genotype
Country OBI dataset non-OBI dataset
Total patients HBV sequences by genotype Total patients HBV sequences by genotype
ACDE ACDE
China 8 8 13 13
Spain 2 2 1 1
Ghana 9 9 9 9
France 1 1 3 2 1
Italy 13 1 12 7 7
India 8 4 4 7 4 3
others 122 19 27 58 18
Total 41 5 8 19 9 162 25 40 70 27
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acid change in both frames; by virtue of code degenera-
tion, the remaining three positions (78, 418 and 2435) pro-
duce no amino acid change in one of the two overlapping
frames, because they occur in third position of the affected
codon. Actually, at the protein level the nucleotide change
in position 78 affects two proteins, the Large and Middle
S, because it is located in the Pre-S2 region, shared by
these proteins. Position 233 has even higher impact;
besides producing amino acid change in two ORFs, it
affects four proteins: in addition to the Polymerase, the
Large, Middle and Small Surface proteins are affected,
because position 233 is located in the region shared by
these three proteins (Table 2).
Careful examination of the well-annotated reference
HBV sequence Acc. No. AM282986 showed that, accord-
ing to annotations herein reported, none of the identified
significant positions occurs in known regulative regions of
HBV genome, such as promoters, enhancer I and II, Post-
transcriptional Regulative Element (PRE), binding sites for
cellular transcription factors, et cetera; likewise, none of
the significant positions occurs in untranslated regions of
HBV mRNAs. Thus, any possible contribution of identi-
fied nucleotide variants to the OBI “phenotype” appears to
be due to the amino acid change in the affected proteins.
Overall, 11 out of 41 OBI sequences (26.8%) showed
significant changes. Thus, the observed variations might
be involved in a fraction but not most OBI.
Multivariable analysis
Multivariable Logistic Regression (LR) with backward
Akaike information criterion (AIC) stepwise selection
was executed on the set of bases/triplets significantly
associated with OBI and non-OBI groups under the
univariable Fisher’s test, in order to assess their
importance by mutual adjustment. Additionally, by
considering the full set of bases/triplets, and 30 inde-
p e n d e n tr u n so fR a n d o mF o r e s t( R F )m o d e l s ,t h e
average Gini index was used as a measure of variable
importance. In addition, Decision Tree (DT) and
Rule Induction (RI) models were trained on the full
data sets. All models were analysed in terms of differ-
ent goodness-of-fit functions, estimating the extra-
sample error via Multiple ten-fold Cross-Validation
(MCV).
Whilst the LR did not produce any set of predictors
showing independent association with the outcome, the
analysis of the Gini importance from the RF yielded sev-
eral significant positions, and all those found to be sig-
nificant by the univariable analysis were confirmed (see
Figure 1 and Table 2).
Performance of the models
Performance of different classification models in terms
of Area Under the receiver operating Characteristic
(AUC), accuracy, true negative rate, and true positive
rate was evaluated. 10 independent runs of 10-fold
cross-validation were executed, using different input sets
and feature selection methods.
The best model in terms of AUC and accuracy was a
RF with the whole set of bases or triplets as input set
(Table 3). The RF trained with the bases as input encod-
ing yielded an average AUC of 0.847 (st.dev.: 0.100) and
accuracy of 83.948 (st.dev.: 5.024).
Table 2 Nucleotide positions significantly enriched in OBI dataset by univariable analysis
Nucleotide
positions*
Adjusted p-
value
Significant nt changes in OBI
vs. non-OBI
Amino acid change in affected open reading frames Affected HBV
protein**
polymerase surface core
pre-S2 S
78 0.0144 G ® A no change Gly ®
Glu
L, M
233 0.0367 A ® G His ® Arg (RT
domain)
Thr ®
Ala
P, L, M, S
418 0.0367 G ® T Ala ® Ser (RT
domain)
no
change
P
2240 *** 0.0097 A ® G Thr ® Val (T helper
epitope) ***
C
2241 *** 0.0144 C ® T Thr ® Val (T helper
epitope) ***
C
2435 0.0367 C ® A no change Gln ® Lys (Arg-rich C-
terminus)
C
2485 0.0367 A ® G Asn ® Ser (TP
domain)
P
* positions in the well-annotated reference HBV sequence Acc.No. AM282986
** L, M, S: Large, Middle and Small S, respectively; P: Polymerase; C: Core
*** nucleotides 2240 and 2241 co-variated in all observed cases, substituting ACT with GTT or ACA with GTA codons.
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RF was always superior in terms of AUC and accuracy,
but not always when considering the true positive or true
negative rate. A reduction of the input set based on the
inclusion of positions significant under univariable analy-
sis did not produce any improvement in the model fits.
Of note, average specificity (true negative rate) was
low for all models, although at a fixed false positive rate
(1-specificity) of 10%, the best RF model was able to
give a 56% of sensitivity (Figure 2).
Analysis of Surface ORF for presence of Stop codons
Stop codons in the Surface ORF might theoretically
account for the absence of serum HBsAg in OBI
patients. Thus, the region coding for the Small surface
protein from OBI and non-OBI cases of our dataset was
analyzed for the presence of Stop codons. The frequency
was found to be higher in OBI than non-OBI sequences
[3 out of 41 (7.3%) OBI vs. 5 out of 162 (3.1%) non-OBI
sequences], but the difference did not reach statistical
significance (Fisher’s exact test: p = 0.19).
Figure 1 Average Gini index as a measure of variable importance. Averaged Gini variable importance extracted from 30 random forest
models trained on the full data set, compared with the average Gini values obtained by re-shuffling the class variable. Variables are ranked
decreasingly by their importance. Only variables with a p-value < 0.05 are depicted.
Table 3 Performance of different classification models
input
encoding
model feature
selection
average
AUC
(st. dev.)
average
accuracy
(st. dev.)
average
TNR
(st. dev.)
average
TPR
(st. dev.)
bases RF none 0.847 (0.100) 83.948 (5.024) 0.220 (0.230) 0.992 (0.021)
triplet RF none 0.847 (0.097) 83.952 (4.820) 0.224 (0.222) 0.990 (0.022)
bases RF Fisher 0.699 (0.160) * 81.462 (5.812) 0.215 (0.226) 0.962 (0.055)
triplet RF Fisher 0.759 (0.127) 81.781 (5.306) 0.234 (0.219) 0.961 (0.047) *
bases LR Fisher/AIC 0.670 (0.134) * 81.310 (6.036) 0.283 (0.220) 0.943 (0.054) *
triplet LR Fisher/AIC 0.680 (0.147) * 81.343 (6.878) 0.324 (0.226) 0.934 (0.058) *
bases DT none 0.570 (0.137) * 79.862 (5.904) 0.143 (0.217) 0.960 (0.059)
triplet DT none 0.549 (0.106) * 80.136 (4.850) * 0.130 (0.203) 0.967 (0.059)
bases RI none 0.574 (0.094) * 80.662 (5.054) 0.190 (0.219) 0.958 (0.072)
triplet RI none 0.579 (0.110) * 79.943 (5.442) 0.215 (0.249) 0.943 (0.074)
* worse than RF on whole set of bases at p < 0.05
AUC: area under the receiver operating characteristic; RF: random forest; LR: logistic regression; DT: decision tree; RI: rule induction; TNR: true negative rate; TPR:
true positive rate; AIC: Akaike information criterion.
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the Small S protein
Recently, high substitution rate in the Small S protein of
genotype D OBI strains, in particular in the Major
Hydrophilic Region (MHR), has been reported; substitu-
tion rate in the MHR was found to be higher in anti-
HBs positive than in anti-HBs negative OBIs, suggesting
an escape mutation mechanism related to imperfect
immune control, that would result in low level viral
replication [7].
We evaluated variation along the 226 predicted amino
acids of the Small S protein of genotype D OBI and
non-OBI sequences by calculating entropy values (Hx).
Comparison of the resulting entropy plots showed
higher entropy values in OBI than in non-OBI group,
despite the higher number of non-OBI sequences (Fig-
ure 3A). The most prominent regions of amino acid var-
iation correspond to amino acids of the “a” determinant
of the S protein (residues 110-140), located inside the
MHR region. These findings confirm that variability in
Small S protein in genotype D is higher in OBIs than in
non-OBIs. The observed amino acid substitutions in the
MHR of the 19 genotype D OBI sequences, as resulting
by comparison with a consensus from non-OBI
sequences, are reported in Figure 3B. Unfortunately, we
could not compare anti-HBs positive vs.a n t i - H B sn e g a -
tive OBIs, because most complete genome sequences for
which patient anti-HBc/anti-HBs status could be
retrieved were anti-HBs negative.
Discussion
The most prominent features of occult hepatitis B are
absence of detectable HBsAg and low level viremia.
Although the underlying mechanisms involved in OBI
remain to be clarified, both features might be due to low
level HBV replication and expression, and it can be hypothe-
sized that at least in some cases they might be caused by
point mutations in regulative elements implicated in the
control of viral replication and expression. Actually, data
from the present study do not support this hypothesis: no
nucleotide variations found to be significantly enriched in
the OBI dataset mapped to known viral regulatory regions.
Thus, the only possible contribution of such variations to
OBI appears to be by amino acid change of HBV proteins.
Mechanisms potentially able to explain low level vire-
mia might involve steps of the replicative cycle such as
assembly, budding and entry of viral particles and/or the
efficiency of viral particle removal by immune system;
indeed, a low viral load might also result from low level
replication in the presence of incomplete immune con-
trol. Mutation in viral proteins might affect any of the
above processes: however, the possible mechanistic bio-
logical link with the occult state is not obvious for all
identified significant amino acid changes.
Figure 2 True positive vs. false positive rate plots of different models trained on the full data set. A higher “Area Under the Curve” (AUC)
means a higher chance to classify a random isolate from the occult group as a true occult hepatitis, as compared to the chance to classify a
random isolate from the wild type group as an occult hepatitis. RF: Random Forest; LR: Logistic Regression; DT: Decision Tree.
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duces a Gly to Glu amino acid change in the Pre-S2
region of the Surface ORF, thus replacing a neutral resi-
due with a negatively charged one. Both the Large and
the Middle S proteins include the amino acids encoded
by the Pre-S2 region, thus both proteins are affected by
the observed change. The Large S, due to alternative
folding, exists in the form of two alternative structures,
one of them mediating virion assembly and the other
involved in virion binding to the cellular receptor.
According to the current model of Large S protein
structure, it can be speculated that the Gly to Glu
change in the Pre-S2 region might affect protein folding
and, thus, one or both processes.
The 233, 418 and 2485 nucleotide substitutions pro-
duce amino acid change in the polymerase, and they
Figure 3 Variation of the Small S protein of genotype D OBI and non-OBI sequences. A: variation along the complete Small S protein of
genotype D OBI and non-OBI sequences shown by entropy plots (see Materials and Methods). Entropy values (Hx) are a measure of variation at
each amino acid position in the set of aligned sequences. It can vary from 0 (i.e. no variation) to 3.04 (i.e. all the possible 20 amino acids or a
gap occur in equal frequency in a position. B: amino acid variations in the MHR of HBsAg in 19 genotype D OBI sequences vs. a consensus from
genotype D non-OBI sequences. Accession number and country of origin of each sequence are reported.
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HBV genome by affecting polymerase activity. In addi-
tion, the 233 substitution also affects the Small S ORF,
shared by the Large S, Middle S and Small S proteins,
producing a Thr (hydrophilic) to Ala (hydrophobic)
amino acid change. Thus, the 233 substitution impacts
simultaneously on 4 different HBV proteins.
Finally, the AC to GT co-variation of nucleotides 2240
and 2241, and the C to A change of nucleotide 2435
resulted in amino acid change in the core ORF, the first
one affecting a T-helper epitope and thus, possibly
interfering with immune response, the other replacing a
polar uncharged with a positively charged amino acid, in
a region already rich of positively charged amino acids.
On the whole, results show that the Polymerase, the
Large, Middle and Small S and the Core proteins, but
not the X, are the targets of the observed significant var-
iations. These findings imply several different viral pro-
teins may contribute to OBI and suggest that
heterogeneous mechanisms are involved in the genesis
or maintenance of occult clinical status.
Overall, in our dataset only 11 out of 41 (26.8%) OBI
sequences showed the identified significant amino acid
variants. Likely, this result might be due to the small
size of the OBI dataset, which affects statistical signifi-
cance and might have precluded identification of further
relevant positions. Nevertheless, it cannot be excluded
that point mutations of HBV genome effectively play a
significant role in one thirdo n l yO B I s ,w i t ho t h e rf a c -
tors being involved in the remaining two thirds. Among
other possible factors might be: (a) co-infection with
other viruses, such as Hepatitis C Virus (HCV), that
might interfere with HBV replication: indeed OBI has
been frequently identified in HCV infected patients
[reviewed in 22]; (b) incomplete immune control by the
host; (c) DNA methylation of HBV genome [23]; (d)
large deletions, rather than point mutations, in regula-
tive elements of HBV genome, as reported in genotype
C OBI patients [24].
Due to the small size of the OBI dataset, we could not
carry out intra-genotype univariable and multivariable
analysis; thus, our data cannot exclude also the existence
of genotype specific variations associated with OBI.
Although the frequency of Stop codons in the S ORF
was higher in OBI than non-OBI sequences, the differ-
ence was not statistically significant. It appears that
absence of circulating HBsAg due to mutations introdu-
cing a Stop codon in the Small S is not a general
mechanism responsible for OBIs, though could be
involved in a fraction of them. Further studies with lar-
ger datasets are needed to better address this point.
An escape mutation mechanism has been associated
with genotype D OBI on the basis of a high substitution
rate in the S protein, particularly in the MHR of anti-
HBs positive OBIs [7]. Analysis of entropy plots of gen-
otype D sequences from our OBI and non-OBI datasets
showed higher variability in OBIs (Figure 3A): the most
prominent regions of amino acid variation correspond
to amino acids 110-140, a region spanning the “a” deter-
minant of the HBV S protein. The “a” determinant is
located within the immunodominant loops and is
included in the MHR (residues 100-151). It is exposed
on the surface of HBV particle and represents a highly
immunogenic region, it is the primary target of neutra-
lizing antibodies and it is common to all HBV geno-
types. However, it remains to be investigated whether in
genotype D OBIs such an escape mechanism is the
main factor or one of several factors responsible for
OBI, as well as whether or not this mechanism also
plays a role in the other genotypes.
Prediction models are being developed as promising
tools to help clinician in diagnosis and patient manage-
ment. In the present study, we evaluated the feasibility
of bioinformatics prediction models to classify HBV
infections into OBI and non-OBI by molecular data.
The performance of the models was evaluated by accu-
racy, AUC, TNR and TPR, four parameters measuring
the prediction property of the test. The overall predic-
tion performance, although showed high accuracy and
AUC, may not be satisfactory in terms of specificity
(TNR and TPR), for any in-silico genotype-based pheno-
type prediction model (Table 3). A more complex input
encoding, considering base triplets instead of single base
positions, produced similar results. The unsatisfactory
performance was likely due to the relatively too small
sample size of OBIs and the highly unbalanced (4:1)
dataset towards non-OBI. However, results are promis-
ing in the perspective of a broader collection of OBI
sequences and indicate the feasibility to derive predic-
tion models to classify HBV infections into OBI and
non-OBI by molecular data.
Conclusions
In summary, computational analysis of complete gen-
ome HBV sequences from OBI and non-OBI patients
showed several different point mutations significantly
associated with OBI. All of them were involved in
amino acid change and none mapped to regulative ele-
ments of HBV genome. All viral proteins, with the
only exception of the X, were found to be targets of
the significant variations, suggesting heterogeneous
mechanisms may contribute to OBI. It is likely that
further variations associated with OBI did not achieve
statistical significance due to the too small size of
available OBI dataset. This factor also limited the spe-
cificity of prediction models, whose performance might
improve in the near future when a larger set of com-
plete genome OBI sequences will become available as
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sequencing” techniques.
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